Author:
Cho Eun Jung,Doh Kyung-Oh,Park Jinho,Hyun Hyesun,Wilson Erin M.,Snyder Paul W.,Tsifansky Michael D.,Yeo Yoon
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Dellinger, R. et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med . 34, 17–60 (2008).
2. Angus, D. C. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit.Care Med. 29, 1303–1310 (2001).
3. Angus, D. C. et al. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit.Care Med. 31, 1–11 (2003).
4. Kumar, V., Abbas, A. K., Fausto, N. & Aster, J. C. Robbins & Cotran Pathologic Basis of Disease . 8th edn (Saunders/Elsevier, 2010).
5. Kaukonen, K. M., Bailey, M., Suzuki, S., Pilcher, D. & Bellomo, R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 311, 1308–1316 (2014).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献